Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control
about
Effects of symbiotic and vitamin E supplementation on blood pressure, nitric oxide and inflammatory factors in non-alcoholic fatty liver disease.Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial.Diabetes is an independent predictor of right ventricular dysfunction post ST-elevation myocardial infarction.Clinical relevance of dual-energy X-ray absorptiometry (DXA) as a simultaneous evaluation of fatty liver disease and atherosclerosis in patients with type 2 diabetes.Assessment of Left Ventricular Structural Remodelling in Patients with Diabetic Cardiomyopathy by Cardiovascular Magnetic ResonanceImpact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis.Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study.Subclinical left ventricular diastolic dysfunction and incident type 2 diabetes risk: the Korean Genome and Epidemiology Study.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Age-dependent development of left ventricular wall thickness in type 2 diabetic (db/db) mice is associated with elevated low-density lipoprotein and triglyceride serum levels.Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patientsLeft atrium passive ejection fraction is the most sensitive index of type 2 diabetes mellitus-related cardiac changes.Association between abdominal adiposity and subclinical measures of left-ventricular remodeling in diabetics, prediabetics and normal controls without history of cardiovascular disease as measured by magnetic resonance imaging: results from the KORA
P2860
Q33667280-571D5D40-7958-4C1B-B629-4C82CFFBD7FCQ35841934-D3EB7BB0-204D-4D27-8604-DAE21BB69FDFQ36348478-BF6B90E0-8A3A-4D09-B8EA-C9D0F270D574Q36596114-50DE079A-31B7-4B6D-9391-083CADE9B27EQ36796925-22B6853F-6382-4B98-949A-294D4047888EQ37067547-80169F44-55BA-4246-9FC0-E85B9F1E37B5Q37526616-AB3C2390-88CD-45BF-8081-E07176DA3425Q37633781-92E04EBB-502C-49E4-AE05-1A2995E805D5Q37700844-5481560A-DA69-4F7F-8DDA-2DCC4FDA43F8Q38711424-8526327D-3EBD-43A9-9883-AE6A23C49AE3Q38845086-C7E593CB-FC25-495F-96E0-9C414FD857DDQ41544135-23C8DE15-C60C-4647-8275-938C6F947D92Q48105315-B8386064-306F-4FB8-A2E7-7B0F24F77987Q55266890-485CD99D-6180-40EE-80E6-E78F2EBE62BF
P2860
Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic control
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cardiac structure and function ...... ssociate with glycemic control
@ast
Cardiac structure and function ...... ssociate with glycemic control
@en
type
label
Cardiac structure and function ...... ssociate with glycemic control
@ast
Cardiac structure and function ...... ssociate with glycemic control
@en
prefLabel
Cardiac structure and function ...... ssociate with glycemic control
@ast
Cardiac structure and function ...... ssociate with glycemic control
@en
P2093
P2860
P50
P1476
Cardiac structure and function ...... ssociate with glycemic control
@en
P2093
Christian Thoma
Christopher P Day
Guy A MacGowan
Kate Hallsworth
Kieren G Hollingsworth
Roy Taylor
P2860
P2888
P356
10.1186/S12933-015-0187-2
P407
P577
2015-02-13T00:00:00Z
P5875
P6179
1005835087